Drugs / NNC 0070-0002-0349
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00728455 | Jul 2008 → Dec 2009 | metabolic disease, obesity disorder | Novo Nordisk A/S | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NNC 0070-0002-0349 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00728455 ↗ |
| Route | Subcutaneous | “subcutaneous injection” NCT00728455 ↗ |